HARMANI KALIM, M. G. F.; ROHMAN, M. S.; SARGOWO, D.; WINARSIH, S.; NUGRAHENNY, D.; SUJUTI, H.; WIDHANINGRUM, S. N.; SOUHALY, J. . W. Empagliflozin Attenuates Cardiac Fibrosis via Suppression of TLR2/NF-κB Signaling in a Rat Model of Metabolic Syndrome. Trends in Sciences, Nakhon Si Thammarat, Thailand, v. 23, n. 9, p. 13423, 2026. DOI: 10.48048/tis.2026.13423. Disponível em: https://tis.wu.ac.th/index.php/tis/article/view/13423. Acesso em: 25 jun. 2026.